CT Crystalys Therapeutics 2026-07-22 $130M Summary Crystalys Therapeutics secures $130M Series B round to advance its biopharmaceutical innovations. Investors Frazier Life SciencesCormorant Asset Managementplus 4 more Categories Biotech Source Seedtable
